Invitae Corporation
NVTA
Rang in aandelen
#35771
Invitae Corporation operates as a medical genetics enterprise, striving to... Invitae Corporation operates as a medical genetics enterprise, striving to integrate genetic insights into mainstream medical practice to enhance healthcare outcomes for individuals in the United States, Canada, and internationally. The company provides a comprehensive suite of offerings, including genetic testing for various clinical specializations such as hereditary cancer, cardiovascular health, neurological disorders, pediatric conditions, oncology, metabolic ailments, and rare diseases, alongside digital health tools and health data services. Its clientele spans individual patients, healthcare providers, biopharmaceutical firms, and other collaborators. Established in 2010 as Locus Development, Inc., the company officially became Invitae Corporation in 2012 and is headquartered in San Francisco, California.
Aandeelprijs
$0.016
Laatst gesynchroniseerd: 2024-03-11
Marktkapitalisatie
$3.27M
Verandering (1 dag)
-5.33%
Verandering (1 jaar)
5,233.33%
Land
US
Handel Invitae Corporation (NVTA)
Categorie
Healthcare
Winst voor Invitae Corporation (NVTA)
Winst in Sep 2023 TTM: $-1.45B
Volgens de meest recente financiële verslagen van Invitae Corporation bedraagt de huidige winst van het bedrijf $-1.45B. In 2022 behaalde het bedrijf een winst van $-3.15B, een daling ten opzichte van de winst van 2021, die $-415.86M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Invitae Corporation van 2016 tot 2026
Winst aan het einde van elk jaar
| Jaar | Winst | Wijzigen |
|---|---|---|
| 2026 (TTM) | $-1.45B | -100.00% |
| 2023 | 0.00 | -100.00% |
| 2022 | $-3.15B | 657.75% |
| 2021 | $-415.86M | -41.78% |
| 2020 | $-714.27M | 174.28% |
| 2019 | $-260.42M | 97.05% |
| 2018 | $-132.16M | 5.52% |
| 2017 | $-125.24M | 24.92% |
| 2016 | $-100.26M | 0.00% |
Winst van vergelijkbare bedrijven of concurrenten
| Bedrijf | Winst | Winstverschil | Land |
|---|---|---|---|
| $7.61B | -623.31% |
US
|
|
| $4.76B | -427.50% |
US
|
|
| $-252.70M | -82.62% |
US
|
|
| - | - |
CN
|
|
| $1.66B | -214.03% |
US
|
